Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Use of Hospital and Emergency Department of Refugee Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03528239
Recruitment Status : Completed
First Posted : May 17, 2018
Last Update Posted : September 4, 2018
Sponsor:
Information provided by (Responsible Party):
Nevsehir Public Hospital

Brief Summary:
After Middle Eastern crisis, millions people were forced to migrate to European countries and especially neighboring countries. In Turkey, cities which are closed to east of border, face to cope more refugees' health care than those of other cities. The incidence of admission of hospital outpatient clinics and emergency department by refugee patients is not known clearly in our city, Nevsehir. In this study, we wanted to investigate use of health care among these patients in Nevsehir in Turkey.

Condition or disease Intervention/treatment
Refugees Health Care Outpatients Emergency Departments Other: Refugee patients

Layout table for study information
Study Type : Observational
Actual Enrollment : 10000 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: The Use of Hospital Outpatient Clinics and Emergency Department by Refugee Patients in Turkey
Actual Study Start Date : January 1, 2014
Actual Primary Completion Date : December 31, 2017
Actual Study Completion Date : May 31, 2018

Resource links provided by the National Library of Medicine



Intervention Details:
  • Other: Refugee patients
    To investigate characteristics of outpatient visits of refugee patients


Primary Outcome Measures :
  1. The incidence of outpatient clinics and emergency department use by refugee patients [ Time Frame: 2014-2017 ]
    Hospital outpatient clinics and emergency department use by refugee patients in a secondary care hospital.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Refugee patients are registered in the hospital system in a different way than that of others. We will use these datas as recorded refugees. And also, we will use the number of other visits to calculate the incidence of visits of refugees.
Criteria

Inclusion Criteria:

All patients who visited an outpatient clinic and emergency department.

Exclusion Criteria:

Patients who have missing records.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03528239


Locations
Layout table for location information
Turkey
Nevsehir State Hospital
Nevsehir, Turkey
Sponsors and Collaborators
Nevsehir Public Hospital
Layout table for additonal information
Responsible Party: Nevsehir Public Hospital
ClinicalTrials.gov Identifier: NCT03528239    
Other Study ID Numbers: Nevşehir
First Posted: May 17, 2018    Key Record Dates
Last Update Posted: September 4, 2018
Last Verified: August 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Emergencies
Disease Attributes
Pathologic Processes